You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

Litigation Details for AstraZeneca AB v. Zydus Pharmaceuticals (USA), Inc. (D. Del. 2021)

✉ Email this page to a colleague

« Back to Dashboard

AstraZeneca AB v. Zydus Pharmaceuticals (USA), Inc. (D. Del. 2021)

Docket	⤷ Sign Up	Date Filed	2021-04-16
Court	District Court, D. Delaware	Date Terminated	2021-11-15
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	10,183,020
Link to Docket	External link to docket

Small Molecule Drugs cited in AstraZeneca AB v. Zydus Pharmaceuticals (USA), Inc.

The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .

Details for AstraZeneca AB v. Zydus Pharmaceuticals (USA), Inc. (D. Del. 2021)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2021-04-16	1	Complaint	prior to the expiration of U.S. Patent No. 10,183,020 (“the ’020 patent”). Case 1:21-cv-00550-UNA Document… 1. This is an action for patent infringement under the patent laws of the United States, Title…admitted in pending patent litigation concerning infringement of the ’020 patent that Cadila is the manufacturer…020 patent in the event that Zydus’s ANDA No. 214263 as amended is approved before the ’020 patent expires… in related patent litigation in this district concerning infringement of the ’020 patent in the Pending	External link to document
2021-11-15	18	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,183,020. (Attachments: # 1… 15 November 2021 1:21-cv-00550 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-04-16	3	ANDA Form	Notice: 3/4/2021. Date of Expiration of Patent: (10,183,020) 01/02/2035.Thirty Month Stay Deadline: 9… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 15 November 2021 1:21-cv-00550 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-04-16	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,183,020. (mal) (Entered: 04… 15 November 2021 1:21-cv-00550 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.